Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Minocycline hydrochloride
Mylan IRE Healthcare Limited
J01AA; J01AA08
Minocycline hydrochloride
100 mg milligram(s)
Modified-release capsule, hard
Product subject to prescription which may not be renewed (A)
Tetracyclines; minocycline
Marketed
1993-06-23
PACKAGE LEAFLET: INFORMATION FOR THE USER MINOCIN SA 100 MG MODIFIED RELEASE CAPSULES minocycline READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE, BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. The name of your medicine is Minocin SA 100 mg modified release capsules, which will be called Minocin SA capsules throughout this leaflet. WHAT IS IN THIS LEAFLET: 1. What Minocin SA capsules are and what they are used for 2. What you need to know before you take Minocin SA capsules 3. How you take Minocin SA capsules 4. Possible side effects 5. How to store Minocin SA capsules 6. Contents of the pack and further information 1. WHAT MINOCIN SA CAPSULES ARE AND WHAT THEY ARE USED FOR Minocin SA capsules contain the active ingredient minocycline, which is an antibiotic. Minocin SA capsules are used to treat acne. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MINOCIN SA CAPSULES DO NOT TAKE MINOCIN SA CAPSULES: - If you are allergic to minocycline, other similar drugs, or any of the other ingredients of Minocin SA capsules (see list of ingredients in section 6). An allergic reaction may include rash, itching, difficulty breathing or swelling of the face, lips, throat or tongue. - If you are pregnant or breast feeding - If you have renal (kidney) failure - If you have severe liver disease - Minocin SA capsules should not be used in children under 12 years of age. WARNINGS AND PRECAUTIONS: Talk to your doctor or pharmacist before taking Minocin SA capsules if you have any of the following conditions: - If you have liver disease - If you have severe kidney disease - If you are taking another drug t Read the complete document
Health Products Regulatory Authority 21 September 2023 CRN00DR6Q Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Minocin SA 100 mg Modified Release Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 100mg of minocycline equivalent to 116 mg of minocycline hydrochloride dihydrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Modified release hard capsules Two piece, hard shell, size 2 capsule with an orange opaque body and a brown cap containing a mixture of off white and coloured (yellow, green, brown/black) spherical pellets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Minocin SA capsules are indicated for the treatment of acne. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION DOSAGE: Adults: One 100mg capsule every 24 hours. Children over 12 years: One 100mg capsule every 24 hours. Children under 12 years: Minocin is not recommended. Elderly: No special dosing requirements. ADMINISTRATION: To reduce the risk of oesophageal irritation and ulceration, the capsules should be swallowed whole with plenty of fluid, while sitting or standing. Unlike earlier tetracyclines, absorption of minocycline is not significantly impaired by food or moderate amounts of milk. Treatment of acne should be continued for a minimum of 6 weeks and where possible limited to a maximum of six months. If, after six months, there is no satisfactory response Minocin SA should be discontinued and other therapies considered. If Minocin SA is to be continued for longer than six months, patients should be monitored (including laboratory investigations) at least three monthly thereafter for signs and symptoms of hepatitis or systemic lupus erythematosus (SLE) or unusual pigmentation (see Special warnings and precautions for use). 4.3 CONTRAINDICATIONS Known hypersensitivity to tetracyclinesor to any of the components of Minocin SA, use inpregnancy, lactation, children under the age of 12 years, complete renal failure. Severe liver disease. Minocin SA contains a small qu Read the complete document